01-01-1970 12:00 AM | Source: Accord Fintech
Glenmark Life Sciences files DRHP for IPO with SEBI
Glenmark Life Sciences has filed a Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) for an initial public offer (IPO). Glenmark Life Sciences is a wholly-owned subsidiary of Glenmark Pharmaceuticals.
The offer comprises fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73,05,245 equity shares of Rs 2 each of Glenmark Life Sciences, by Glenmark Pharmaceuticals.
The board of directors of Glenmark Pharmaceuticals during its meeting on April 16 approved the offer for sale of up to 73,05,245 equity shares of Rs 2 apiece as part of the IPO. The IPO will be subject to market conditions, receipt of applicable approvals and other considerations.
Latest News
Remsons Industries trades higher on the BSE
Agri Commodity Technical Report 19 April 2024 - Geoj...
MCX Crude oil is likely to rise back towards 7250 le...
Commodity Intraday Technical Outlook 19 April 2024 -...
Agilitas Sports acquires exclusive rights for Lotto ...
The Indian rupee is expected to open with a cut amid...
Salesforce rolls out 'Slack AI' to all paid customer...
Buy JPYINR Apr @ 54 SL 53.8 TGT 54.2-54.4 - Kedia Ad...
MCX Gold is likely to trade with positive bias durin...
Volumes of domestic mining, construction equipment l...